<DOC>
	<DOC>NCT01347086</DOC>
	<brief_summary>The aim of the study is to evaluate safety, tolerability and pharmacokinetics in Asian and Caucasian healthy male volunteers administered BI 207127 NA.</brief_summary>
	<brief_title>Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: 1. Healthy male volunteers 2. Chinese ethnicity or Japanese ethnicity or Caucasian 3. Body Mass Index (BMI) = 18.5 and BMI =25 kg/m2 for Japanese and Chinese, BMI =18.5 and BMI = 29.9 kg/m2 for Caucasians Exclusion criteria: 1. Any finding of the medical examination (including Blood pressure(BP), Pulse rate (PR) and Electrocardiogram (ECG)) deviating from normal and of clinical relevance 2. Any evidence of a clinically relevant concomitant disease 3. Intake of drugs with a long halflife (&gt; 24 hours) within at least one month or less than 10 halflives of the respective drug prior to administration or during the trial</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>